Published in Am J Kidney Dis on December 01, 2002
Blood lead level and kidney function in US adolescents: The Third National Health and Nutrition Examination Survey. Arch Intern Med (2010) 1.37
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ (2010) 1.18
Racial disparities in kidney health: the puzzle to solve. Am J Kidney Dis (2002) 0.95
Characterization of the BRAZPD II cohort and description of trends in peritoneal dialysis outcome across time periods. Perit Dial Int (2014) 0.95
Limited referral to nephrologists from a tertiary geriatric outpatient clinic despite a high prevalence of chronic kidney disease and anaemia. BMC Geriatr (2012) 0.80
Oral health in predialysis patients with emphasis on diabetic nephropathy. Clin Oral Investig (2010) 0.78
Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963-2014). Popul Health Metr (2017) 0.78
Hemodialysis in patients older than 65 years with end-stage renal failure--comparison of outcome in patients with and without diabetes. Z Gerontol Geriatr (2008) 0.75
A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med (2010) 10.33
Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2008) 4.72
Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol (2003) 4.15
The ultrafiltration coefficient of a dialyser (KUF) is not a fixed value, and it follows a parabolic function: the new concept of KUF max. Nephrol Dial Transplant (2010) 2.75
Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol (2004) 2.66
Cost-effectiveness of initiating dialysis early: a randomized controlled trial. Am J Kidney Dis (2011) 2.62
Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med (2002) 2.54
Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int (2010) 2.10
Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2004) 1.93
Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status. Am J Kidney Dis (2012) 1.91
Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2004) 1.75
Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol (2006) 1.67
Home haemodialysis in Australia - is the wheel turning full circle? Med J Aust (2010) 1.67
Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice. Nephrol Dial Transplant (2010) 1.62
Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis (2004) 1.62
A single low-fixed dose of rituximab to salvage renal transplants from refractory antibody-mediated rejection. Transplantation (2009) 1.49
Prospective psychosocial monitoring of living kidney donors using the SF-36 health survey. Transplantation (2003) 1.44
Anorexia nervosa and senna misuse: nephrocalcinosis, digital clubbing and hypertrophic osteoarthropathy. Med J Aust (2008) 1.43
Native arteriovenous fistula blood flow and resistance during hemodialysis. Am J Kidney Dis (2003) 1.43
Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant (2007) 1.42
Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol (2003) 1.41
Transient bone marrow edema in renal transplantation: a distinct post-transplantation syndrome with a characteristic MRI appearance. Am J Transplant (2002) 1.40
The Initiating Dialysis Early and Late (IDEAL) study: study rationale and design. Perit Dial Int (2004) 1.40
Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int (2004) 1.38
Atherosclerosis and folic acid supplementation trial in chronic renal failure: baseline results. Nephrology (Carlton) (2004) 1.38
Desensitization for renal transplantation: depletion of donor-specific anti-HLA antibodies, preservation of memory antibodies, and clinical risks. Transpl Int (2011) 1.38
Home hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis (2011) 1.37
Generation of induced pluripotent stem cells from human kidney mesangial cells. J Am Soc Nephrol (2011) 1.36
Effect of timing of dialysis commencement on clinical outcomes of patients with planned initiation of peritoneal dialysis in the IDEAL trial. Perit Dial Int (2012) 1.25
Health-related quality of life in Australian adults with renal insufficiency: a population-based study. Am J Kidney Dis (2003) 1.24
Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients. Kidney Int (2002) 1.21
Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD. Am J Kidney Dis (2007) 1.20
Renal dialysis abatement: lessons from a social study. Palliat Med (2005) 1.17
The directed differentiation of human iPS cells into kidney podocytes. PLoS One (2012) 1.15
Effect of a vascular access nurse coordinator to reduce central venous catheter use in incident hemodialysis patients: a quality improvement report. Am J Kidney Dis (2008) 1.15
Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int (2012) 1.15
Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Pediatr Nephrol (2011) 1.12
Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991-2001. Nephrol Dial Transplant (2002) 1.12
Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study. Nephrol Dial Transplant (2008) 1.10
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial. Nephrol Dial Transplant (2010) 1.10
Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Kidney Int (2011) 1.09
Increasing home based dialysis therapies to tackle dialysis burden around the world: a position statement on dialysis economics from the 2nd Congress of the International Society for Hemodialysis. Nephrology (Carlton) (2011) 1.06
Arterial function after successful renal transplantation. Kidney Int (2004) 1.04
Time and exercise improve phosphate removal in hemodialysis patients. Am J Kidney Dis (2004) 1.03
Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue. Clin J Am Soc Nephrol (2008) 1.02
How Australian nephrologists view home dialysis: results of a national survey. Nephrology (Carlton) (2011) 1.02
Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Nephrology (Carlton) (2006) 1.02
Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial. Nephrology (Carlton) (2011) 1.00
Does monthly native arteriovenous fistula blood-flow surveillance detect significant stenosis--a randomized controlled trial. Nephrol Dial Transplant (2006) 1.00
Effect of advanced aftertreatment for PM and NO(x) control on heavy-duty diesel truck emissions. Environ Sci Technol (2009) 0.95
Longitudinal body composition changes due to dialysis. Clin J Am Soc Nephrol (2011) 0.94
Burden of end-stage renal disease among indigenous peoples in Australia and New Zealand. Kidney Int Suppl (2003) 0.94
Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients? Nephrology (Carlton) (2008) 0.93
Trends in kidney transplantation in Australia and New Zealand, 1993-2004. Transplantation (2007) 0.93
Thalassemia bone disease: a 19-year longitudinal analysis. J Bone Miner Res (2014) 0.93
Atrial fibrillation in haemodialysis patients: do the guidelines for anticoagulation apply? Nephrology (Carlton) (2007) 0.92
Vascular calcification and arterial stiffness in chronic kidney disease: implications and management. Nephrology (Carlton) (2007) 0.92
Prospective psychosocial monitoring of living kidney donors using the Short Form-36 health survey: results at 12 months. Transplantation (2004) 0.92
Severe intestinal involvement in Wegener's granulomatosis. J Gastroenterol Hepatol (2003) 0.91
Review of dialysate calcium concentration in hemodialysis. Hemodial Int (2006) 0.91
Graft loss following renal transplantation in Australia: is there a centre effect? Nephrol Dial Transplant (2002) 0.91
Is computerized tomography useful in identifying abdominal catastrophes in patients presenting with peritonitis? Perit Dial Int (2008) 0.91
Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial. Am J Kidney Dis (2010) 0.91
Donor human leukocyte antigen specific antibodies predict development and define prognosis in transplant glomerulopathy. Hum Immunol (2011) 0.90
Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients. Hemodial Int (2008) 0.89
Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis. Am J Nephrol (2011) 0.89
Successful treatment of pulmonary mucormycosis in a renal transplant recipient with limited pulmonary reserve by combined medical and surgical therapy. Heart Lung Circ (2008) 0.89
Determination and validation of aortic calcification measurement from lateral bone densitometry in dialysis patients. Clin J Am Soc Nephrol (2008) 0.87
Vascular access practice patterns in the New Zealand hemodialysis population. Am J Kidney Dis (2004) 0.87
Effect of early initiation of dialysis on cardiac structure and function: results from the echo substudy of the IDEAL trial. Am J Kidney Dis (2012) 0.87
Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients. Clin Transplant (2012) 0.87
Renal transplantation reverses functional deficiencies in circulating dendritic cell subsets in chronic renal failure patients. Transplantation (2006) 0.86
Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005. Nephrology (Carlton) (2008) 0.86
Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD. Am J Kidney Dis (2013) 0.86
25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. BMC Nephrol (2012) 0.86
Outcomes of kidney transplantation from older living donors. Transplantation (2013) 0.86
Acute renal failure in patients with pre-existing renal dysfunction following coronary artery bypass grafting. Nephrology (Carlton) (2005) 0.85
Associations between use of cyclosporine-sparing agents and outcome in kidney transplant recipients. Kidney Int (2002) 0.84
Donor-recipient age matching improves years of graft function in deceased-donor kidney transplantation. Nephrol Dial Transplant (2010) 0.84
Perioperative blood pressure control, delayed graft function, and acute rejection after renal transplantation. Transplantation (2003) 0.84
Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients. Australas J Dermatol (2002) 0.84
Lack of impact of donor age on patient survival for renal transplant recipients ≥60years. Transpl Int (2012) 0.84
Seasonal modifications in blood pressure are mainly related to interdialytic body weight gain in dialysis patients. Kidney Int (2004) 0.83
Usefulness of tachycardic-stress perfusion imaging to predict coronary artery disease in high-risk patients with chronic renal failure. Am J Cardiol (2003) 0.83
The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetes. Nephrology (Carlton) (2008) 0.83
Epidemiology of vascular access in the Australian hemodialysis population. Kidney Int (2003) 0.83
Gene therapy to improve pancreatic islet transplantation for Type 1 diabetes mellitus. Curr Diabetes Rev (2010) 0.83
Robotic remote presence technology in the surgical intensive care unit. J Trauma Acute Care Surg (2012) 0.83
Home hemodialysis in Australia and New Zealand: how and why it has been successful. Semin Dial (2011) 0.82
Immunophenotyping of interstitial infiltrate does not distinguish between BK virus nephropathy and acute cellular rejection. Nephrology (Carlton) (2009) 0.82
Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients. Nephrology (Carlton) (2010) 0.82
Effect of exercise on albuminuria in people with diabetes. Nephrology (Carlton) (2011) 0.81
Prospective quality-of-life monitoring of simultaneous pancreas and kidney transplant recipients using the 36-item short form health survey. Am J Kidney Dis (2010) 0.81
Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial. Nephrol Dial Transplant (2009) 0.81
Outcomes of extended-hours hemodialysis performed predominantly at home. Am J Kidney Dis (2012) 0.81
Thrice-weekly nocturnal hemodialysis: the overlooked alternative to improve patient outcomes. Nephrol Dial Transplant (2013) 0.81
A rational guide to reducing fracture risk in dialysis patients. Semin Dial (2010) 0.81
Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month. Ther Drug Monit (2002) 0.80
Cardiovascular risk in dialysis patients: a comparison of risk factors and cardioprotective therapy between 1996 and 2001. Nephrology (Carlton) (2003) 0.80